MustGrow Board Of Directors and Advisors
Access information on each team member by clicking on their names to view their bios
Corey Giasson - President, CEO & Director
President, CEO & Director
Corey is an entrepreneur who has been focused on the agriculture, potash, oil and gas, mining, and real estate industries specifically in his home province of Saskatchewan, for the past 20 years. He is co-founder and director of Legacy Capital Corp., which is a private equity company focused on participating in management buyouts of strong sustainable cash flowing businesses.
In 2009, Corey co-founded a Saskatchewan based heavy oil company, Rallyemont Energy Inc., where he served as President and CEO. Rallyemont successfully explored for and delineated the Prince Thermal Heavy Oil Project and sold to Husky Energy in December 2013. Prior to Rallyemont, Corey was an independent consultant to a group of companies, including PanWestern Energy Inc. (TSXV-PW), Infrastructure Materials Corp. (OTCBB-IFAM), and Anglo Potash Ltd. (TSXV-AGP), which was formerly Anglo Minerals Ltd. (TSXV-ALM). At Anglo, he held the title of Vice President, Business Development and Investor Relations and was instrumental in marketing the company across Canada and into Europe. Anglo was acquired by its joint venture partner, BHP Billiton, in July 2008 for $284 million.
Prior to joining Anglo, Mr. Giasson was employed by PotashCorp, where he held the title of Manager, Market Research. He has a MBA and B.Sc. in Agriculture Economics, both from the University of Saskatchewan.
Colin Bletsky - COO & Director
COO & Director
Colin Bletsky grew up in Eastern Saskatchewan on a third-generation family farm growing canola, oats and wheat, a tradition he and his family continue each year during seeding and harvest. Today the majority of Colin’s time is spent helping farmers grow sustainable food, both locally and globally.
Colin is currently the Chief Operating Officer for MustGrow Biologics Corp., where he is responsible in helping growers produce pest free crops utilizing natural, science-based technologies. With a passion for utilizing natural technologies, he is also helping producers and consumers in multiple industries understand what nature has to offer to help in production, shipping and storage of food.
During his time as Vice President of Novozymes, Colin was responsible for managing the company’s global BioAg business, ensuring sustainable growth for Novozymes and its partners. Within his role Colin set strategy and direction, and managed partnering activities with internal and external stakeholders. was also a member of the Monsanto and Novozymes Alliance board. From 2010 to 2014, Colin worked in Novozymes BioAg Business Development and Account Management, which spanned North America, South America, Australia, Europe and Asia.
Colin gained agricultural experience through his time in the retail and seed industry with several companies, including Pioneer, in rural Saskatchewan in the late 90s. He then spent close to ten years with increasing management and project responsibilities in sales and marketing, nationally and internationally, in the crop protection industry with Syngenta.
In addition to Colin’s three decades of agricultural business experience he holds a Bachelor of Science in Agriculture from the University of Saskatchewan, Executive education from both the London School of Business and INSEAD and was a Certified Crop Advisor. He is based in Saskatoon, Saskatchewan, with his wife and two children.
Todd Lahti - CFO
Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. Prior to this, he was Treasurer of PartnerRe Ltd., one of the largest reinsurance companies in the world. There he participated in large international mergers and acquisitions and financing initiatives and had responsibilities in investment management, investor relations, capital management and financial operations. He has closed over 50 mergers and acquisitions, financing and licensing transactions totalling over USD $2.4 billion. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
Brad Munro - Chairman
Mr. Munro is the President and Chief Executive Officer of Bittercreek Capital Corporation, a private investment and advisory firm. Through Bittercreek Capital Corporation Mr. Munro was a contractor to GrowthWorks Capital WV Ltd. and its affiliates in the role of Vice President, Investments from May 2006 to August 2009. Prior thereto, Mr. Munro was an employee of Working Ventures Investment Services Inc. and its affiliates since September 1991.
Mr. Munro holds a Bachelor of Commerce degree from the University of Saskatchewan and has extensive experience in corporate finance and investment in the oil and natural gas and other industries. Mr. Munro was previously a director of Zedcor Energy Inc., which is listed on the TSX Venture Exchange and currently sits on the board of two private companies. Mr. Munro was a director of Tervita (or its predecessors) for eight years and was the lead director of the independent committee on the privatization of Tervita.
David Borecky - Director
David is currently CFO at Impossible Foods Inc. where he oversees the company’s financial reporting, corporate accounting, global financial and procurement operations, and internal controls function.
David was previously Controller at financial technology infrastructure provider, Stripe Inc., where he scaled and managed various accounting, finance, and treasury functions from 2016 to 2019. From 2014 through 2016, David held senior management positions at mobile payments and point of sale solution provider, Square Inc. (NYSE:SQ), where he built global finance and accounting operations and worked alongside executives to successfully lead Square's IPO registration process. He also drove corporate development initiatives where he was responsible for sourcing, executing, and integrating strategic acquisitions. Prior to Square, David held leadership roles in treasury and finance at OpenText Corp. (NASDAQ/TSX:OTEX), a global leader in enterprise information management and Canada's largest publicly traded software company.
David holds an honors degree in business from Wilfrid Laurier University and a Masters degree from Schulich School of Business at York University. He is a Canadian Chartered Accountant, a U.S. Certified Public Accountant, and also holds the CIM, PFP, and CF designations.
Matt Kowalski - Director
Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. He became president of Natural Industries, a family founded business focused on biological pest control, from 2002-2012. Under his leadership, Natural Industries was awarded five EPA registrations; three biofungicides, a bionematicide and a bioinsecticide. He worked closely with researchers, distributors and growers, pioneering the effort to educate the industry and push for a wider adoption of biologicals as whole. In addition, Matt spearheaded international distribution and long-term strategic partnerships, decisively positioning the company for global expansion.
Matt directly implemented the launch of Actinovate®, Natural Industries’ flagship product, and shepherded it to become one of the premiere biofungicides in the fruit and vegetable market. Growth at Natural Industries was intentionally methodical, fueled only by cash flow with no infusion of outside capital. By 2012 Natural Industries had 26 employees, no debt and was growing organically at 20-40% per year.
In November 2012, Matt led the strategic sale of Natural Industries to Novozymes BioAg. At Novozymes, he became part of the Global Business Development team taking his place as the biocontrol manager for Novozymes. Matt left Novozymes in April of 2015. His current investments, which include real estate, hospitality, and biotechnology, are directed through his investment corporation, Stronghold Keep. He also sits on the board of directors for VRM Labs, a startup that has a patented natural antioxidant preservative for pet and animal feed.
Tom Flow - Director
Tom Flow is currently the Managing Director of Holigen, a medical cannabis company based in Portugal and owned by Akanda Corp, a Nasdaq listed company. Tom has held several C-level executive roles at Canadian cannabis companies including; The Flowr Corporation and MedReleaf Corp. which was recently sold for $3.2B. Tom is an advisor and sits on the board of several cannabis companies. He is widely-recognised for cannabis thought leadership and expertise building and operating cannabis cultivation facilities.
Laura Westby - Director
Dr. David Maenz, PHD. - Production Advisor
David Maenz, PHD.
- Inventor or co-inventor of 7 patents
- Expert in processing and extraction from oilseeds
Dr. Matthew J. Morra - Scientific Advisor
Dr. Matthew J. Morra
Matthew J. Morra is a Professor Emeritus of Soil Biochemistry at the University of Idaho in Moscow, Idaho. He obtained his B.A. from the College of Wooster in Wooster, Ohio, M.E.M from Duke University, and Ph.D. from Ohio State University. His research program is focused on the fate and transport of synthetic and natural organics in soil and water systems. He has expertise in developing biopesticides, is a leading expert on value-added products derived from oilseeds, and has published over 100 scientific articles and book chapters.
Mark Hetherington, M.Sc. Analytical Chemistry, PChem
Mark Hetherington, M.Sc. Analytical Chemistry, PChem
Mark Hetherington is a natural products formulation and innovation specialist with over 20 years of experience across several platforms. His extensive experience also encompasses analytical method development and QA/QC for Health Canada and FDA compliant sites.
With a focus on commercializable technologies, he is an inventor on several granted patents and patent applications involving the isolation, characterization, and formulation of bioactive natural products and the application of these to commercial products/processes in the cosmetics, nutraceutical, and agricultural sectors.
Mark co-authored a reference publication on the phytochemistry of native and naturalized plant species of the Canadian prairies and has forged a critical link between raw botanical input supply and certified industry natural product inputs.
He has played a pivotal role in R&D and technology management for several successful startup companies.
Jamieson Bondarenko CFA, CMT - Capital Markets Advisor
CFA, CMT - Capital Markets Advisor
- Current: Chairman of BriaCell Therapeutics Corp.
- Previous Equity Capital Markets roles with Eight Capital, Dundee, HSBC